Table 1 Demographic data, comorbidities, and SOFA score of the studied groups
Group A (n = 30) | Group B (n = 30) | Group C (n = 30) | p-value | ||
|---|---|---|---|---|---|
Age (years) | 47.8 ± 10.7 | 46.7 ± 10.3 | 52.2 ± 11.4 | 0.125 | |
Sex | Male | 20 (66.7%) | 18 (60.0%) | 22 (73.3%) | 0.549 |
Female | 10 (33.3%) | 12 (40.0%) | 8 (26.7%) | ||
Hypertension | 11 (36.7%) | 10 (33.3%) | 8 (26.7%) | 0.700 | |
Diabetes mellitus | 12 (40.0%) | 9 (30.0%) | 11 (36.7%) | 0.712 | |
Cancer type | Breast | 18 (60.0%) | 14 (66.7%) | 15 (50.0%) | 0.768 |
Pancreas | 3 (10.0%) | 6 (20.0%) | 6 (20.0%) | ||
Colorectal | 9 (30.0%) | 10 (33.3%) | 9 (30.0%) | ||
Infection source | Pneumonia | 16 (53.3%) | 14 (46.7%) | 15 (50.0%) | 0.962 |
Intraabdominal | 10 (33.3%) | 11 (36.7%) | 10 (33.3%) | ||
Urinary tract | 3 (10.0%) | 3 (10.0%) | 2 (6.7%) | ||
Others | 1 (3.3%) | 2 (6.7%) | 3 (10.0%) | ||
SOFA score | 10 (9–12) | 10 (9–12) | 10 (8–11) | 0.185 | |